Benefits
LDL cholesterol with carob pod fiber
In a placebo-controlled trial of 58 adults with high cholesterol, 15 g/day of carob pulp fiber baked into bread and a fruit bar was followed by a 10.5% fall in LDL cholesterol over 6 weeks. A second trial in 88 adults taking 4 g twice daily of a polyphenol-rich insoluble carob fiber reported a 22.5% LDL drop from baseline after 4 weeks, while the placebo group's lipids did not change significantly. Both trials were small and short.
Insulin and blood sugar markers with inositol-rich carob extracts
In 40 healthy adults, a carob extract drink with about 2 g of inositols taken twice daily for 12 weeks lowered insulin, HOMA-IR and post-meal glucose, while a comparison group on a sugar-sweetened drink gained BMI and fasting glucose. A 90-day maker-funded trial in 52 adults with prediabetes found lower HbA1c and glucose than placebo. In a 44-person trial, insulin and HOMA-IR improved only in participants without obesity.
Post-meal blood sugar response to carob foods and carob fiber
Results depend on the form. A carob snack had a glycemic index of 40 versus 78 for a chocolate cookie and, eaten before lunch, lowered the blood sugar rise after the meal. But 5 or 10 g of carob pulp fiber stirred into a glucose drink raised blood glucose 47% and 64% more than the drink alone. A review of 15 carob trials found that fiber or powder taken in liquid form gave weak or variable effects.
Ghrelin, appetite and food intake
In 20 healthy adults, a liquid meal with carob fiber lowered post-meal acylated ghrelin, the active form of a hunger hormone. The effect did not hold in other settings: the day after eating 50 g of carob fiber, fasting acylated ghrelin was higher. Separately, a carob snack eaten before lunch reduced hunger ratings and calories eaten at the meal in 50 adults, a same-day effect of a snack food.
Body weight and waist size
In 72 healthy adults taking 10 g of carob syrup on 6 days a week for 6 weeks, waist size fell 3.6 cm while it rose in the control group, but the 0.5 kg weight difference was not significant. In young taekwondo athletes, one report found more weight loss on carob than placebo over 6 weeks, while a later report from the same team found about 2 kg lost in both groups. Weight did not change in the 90-day prediabetes trial.
Oxidative stress markers during athletic training
In a double-blind trial of 22 taekwondo athletes, 40 g/day of carob pod powder in water for 6 weeks raised the antioxidant enzymes catalase and superoxide dismutase, lowered malondialdehyde, a marker of fat oxidation, and improved repeated kick performance compared with a carob-flavored placebo drink. This is a single small trial from one research team.
Mechanism of action
Tannin-rich fiber binds bile acids in the gut
In a laboratory study, carob flour bound large amounts of bile acids, mainly through its tannins and insoluble components, and roasting cut that binding by up to 40%. Bile acid binding is one proposed route for the LDL results in carob fiber trials, but it has not been measured in people taking carob.
D-pinitol and insulin signaling
Carob pod syrups and extracts contain D-pinitol, an inositol studied as an insulin mimetic. In healthy volunteers, oral D-pinitol was absorbed slowly, and a single 15 mg/kg dose lowered insulin without changing glucose. Taken in a carob syrup, its peak blood level was about 40% of that expected, probably because the syrup's sugars compete for absorption.
Polyphenol-rich fiber and gut hormones
In an acute human study, carob fiber lowered post-meal acylated ghrelin, triglycerides and free fatty acids and shifted fuel use toward fat, while total ghrelin and insulin did not change. Why a polyphenol-rich insoluble fiber would do this is not known, and in a next-day study by the same group, fasting acylated ghrelin was higher after carob fiber.
Clinical trials
Randomized, double-blind, placebo-controlled parallel trial of bread and a fruit bar with or without carob pulp fiber, 15 g/day for 6 weeks (Zunft et al. 2003, Eur J Nutr)
58 adults with high cholesterol in Germany (29 carob fiber, 29 placebo foods).
LDL cholesterol fell 10.5% with carob fiber (p = 0.010); the abstract does not say whether this is a change from baseline or a difference from placebo. The fall in the LDL:HDL ratio compared with placebo was borderline (p = 0.058). Triglycerides fell 11.3% in women, and the lipid effects were larger in women than in men.
Randomized, double-blind, placebo-controlled parallel trial of an insoluble carob fiber very rich in polyphenols, 4 g twice daily for 4 weeks (Ruiz-Roso et al. 2010, Plant Foods Hum Nutr)
88 adults with high cholesterol in Spain (43 carob fiber, 45 placebo).
From baseline, total cholesterol fell 17.8%, LDL 22.5%, the LDL:HDL ratio 26.2% and triglycerides 16.3% on carob fiber, while the placebo group's lipids did not change significantly. The abstract reports within-group changes rather than a direct between-group comparison.
Double-blind trial of a carob extract drink with 2.23 g of inositols per serving, taken twice daily, versus a sucrose-sweetened drink for 12 weeks (Bañuls et al. 2016, Clin Nutr)
40 healthy adults in Spain.
The inositol drink lowered insulin, HOMA-IR and apolipoprotein B, increased LDL particle size and reduced post-meal glucose by about 14% on continuous glucose monitoring. The sugar-drink group's BMI and fasting glucose rose. The control was a sugar drink rather than a sugar-free placebo, which may enlarge the difference.
Randomized, double-blind, placebo-controlled trial of an inositol-containing carob liquid concentrate at 6.66 g/day in two doses for 90 days, funded by the product's maker (Pérez-Piñero et al. 2026, Nutrients)
52 adults with prediabetes in Spain (25 active, 27 placebo), mean age 45.6.
HbA1c and glucose improved compared with placebo. HOMA-IR, QUICKI and the glucose and insulin responses in a glucose tolerance test improved in the active group only. Total cholesterol, triglycerides and HDL did not change in either group. Body weight did not change, and no adverse effects were recorded.
Two randomized controlled trials of two commercial carob syrups: a glycemic index test and a 6-week trial of 10 g a day, 6 days a week, on blood lipids and body measurements (Planes-Muñoz et al. 2025, Foods)
Healthy adults aged 18 to 65 in Spain: 20 in the glycemic test, 72 in the 6-week trial.
Both syrups had glycemic index values of about 56 and 60 and a 16% smaller glucose response than glucose. Over 6 weeks, total cholesterol fell 14.7 mg/dL on carob syrup and 9.6 mg/dL on the control syrup; only the carob group's fall was significant from baseline, and no lipid difference between groups was significant. Waist size fell 3.6 cm on carob syrup and rose in the control group. The 0.5 kg weight difference was not significant.